Skip to main content
SpringerLink
Log in

Similar Helicobacter pylori Eradication Rate in Obese Patients Undergoing Gastric Bypass Surgery and in General Population

  • Letter to the Editor
  • Published:
Obesity Surgery Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Malfertheiner P, Mégraud F, O'Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. https://doi.org/10.1136/gutjnl-2016-312288.

    Article  CAS  PubMed  Google Scholar 

  2. Pellicano R, Ribaldone DG, Fagoonee S, et al. A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Panminerva Med. 2016;58(4):304–17.

    PubMed  Google Scholar 

  3. Cerqueira RM, Correia MR, Vilar H, et al. How effective is the quadruple concomitant Helicobacter pylori eradication therapy for obese patients undergoing gastric bypass surgery? Obes Surg. 2016;26(6):1163–6. https://doi.org/10.1007/s11695-015-1920-3.

    Article  PubMed  Google Scholar 

  4. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report. Gut. 2012;61(5):646–64. https://doi.org/10.1136/gutjnl-2012-302084.

    Article  CAS  PubMed  Google Scholar 

  5. Cerqueira RM, Correia MR, Vilar H, et al. Cumulative Helicobacter pylori eradication rates by adopting first- and second-line regimens proposed by the Maastricht IV consensus in obese patients undergoing gastric bypass surgery. Obes Surg. https://doi.org/10.1007/s11695-017-2915-z.

  6. Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62(1):34–42. https://doi.org/10.1136/gutjnl-2012-302254.

    Article  CAS  PubMed  Google Scholar 

  7. Miyaki A, Yamaguchi K, Ida A, et al. An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility. Minerva Gastroenterol Dietol. 2016;62(3):234–9.

    PubMed  Google Scholar 

  8. Ribaldone DG, Astegiano M, Saracco G, et al. Amoxycillin and metronidazole therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy. Balkan Med J. 2017;34:290–1.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Financial Support

None

Author information

Authors and Affiliations

  1. Unit of Gastroenterology, S. Giovanni Battista (Molinette) Hospital, Torino, C.so Bramante 88, 10126, Turin, Italy

    Rinaldo Pellicano

Authors
  1. Rinaldo Pellicano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rinaldo Pellicano.

Ethics declarations

Conflict of Interest

The author declares that he has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pellicano, R. Similar Helicobacter pylori Eradication Rate in Obese Patients Undergoing Gastric Bypass Surgery and in General Population. OBES SURG 28, 553–554 (2018). https://doi.org/10.1007/s11695-017-3038-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-017-3038-2

Search

Navigation